A Study of BGM-2121 in Patients With Advanced Solid Tumors
Clinical trial NCT07346846 · RECRUITING
Trial details
- NCT number
- NCT07346846
- Sponsor
- BioGate Precision Medicine Corp.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-10
- Primary completion
- 2027-11-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.